Table 4.
Reasons participants provided for deciding not to continue in the trial during the screening phase.
| Main reason for refusing to continue trial participation | Group 1 PICFv 1.4 % response |
Group 2 PICFv 1.5 % response |
Pearson's chi square P Value |
|---|---|---|---|
| Concerns over potential treatment side effects | 23.6 | 13.7 | 4.481 |
| 0.034 | |||
| Family influence | 17.0 | 10.2 | 2.704 |
| 0.100 | |||
| Unstable health | 5.0 | 11.1 | 4.606 |
| 0.032 | |||
| Too many competing demands | 7.0 | 9.4 | 0.130 |
| 0.718 | |||
| Unwilling to take study medication | 12.3 | 12.0 | 0.054 |
| 0.816 | |||
| Other reasons (combined categories with smaller %) | 35.1 | 43.6 | – |
Notes: Significant at probability alpha level 0.05; PICF = Participant Information and Consent Form.